NIIN Output Data
NIIN:
NSN:
Item Name:
POTASSIUM PHOSPHATES INJECTION , U
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
NDC00469-8600-50 | 60567 | A | 3 | 2 | 6 | 54 | ||
8515P | 60567 | A | 3 | 2 | 6 | 54 |
CAGE Information
Code | Company |
---|---|
60567 | LYPHOMED INC DIV OF FUJISAWA USA INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
FEAT | SPECIAL FEATURES | PRESERVATIVE FREE; 15 ML. SOLUTION IN A 30 ML. SIZE VIAL |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 4.400 MILLIEQUIVALENTS POTASSIUM PER MILLILITER AND 3.000 MILLIMOLES PHOSPHATE PER MILLILITER |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
CQCT | PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 15.000 MILLILITERS |